The studies evaluating the effect of biological therapy on Wnt pathway in RA were mainly focused on TNFα inhibitors, IL-1 receptor antagonist (IL-1Ra) anakinra and anti-IL-6 monoclonal antibody tocilizumab. The gene discussed is IL6; the disease is rheumatoid arthritis.